Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 985 products on this category.

Product data	Purity	Price range	Estimated delivery
1-(Cyclopropylcarbonyl)piperazine Hydrochloride REF: 86-MM3926.01-0025CAS: 1021298-67-8	- - -	To inquire	Wed 18 Dec 24
Palbociclib REF: 86-MM3729.00-0250CAS: 571190-30-2	- - -	2,214.00 €	Wed 18 Dec 24
Enzalutamide REF: 86-MM3917.00-0250CAS: 915087-33-1	- - -	1,226.00 €	Wed 18 Dec 24
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile REF: 86-MM3926.07-0025CAS: 1021298-68-9	- - -	To inquire	Wed 18 Dec 24
Fulvestrant REF: 86-MM3296.00CAS: 129453-61-8	- - -	295.00 €	Wed 18 Dec 24
Carfilzomib REF: 86-MM3929.00-0250CAS: 868540-17-4	- - -	2,086.00 €	Wed 18 Dec 24
7α-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfonyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol (Fulvestrant Sulfone) REF: 86-MM3296.01-0025CAS: 98008-06-1	- - -	1,033.00 €	Wed 18 Dec 24
Folinic acid REF: TM-T24403CAS: 58-05-9	99.7%	36.00 €~222.00 €	Wed 18 Dec 24
Tamoxifen EP Impurity G REF: 4Z-T-0118CAS: 68047-07-4	- - -	To inquire	Fri 27 Dec 24
Oxo-2-pyridinylaminoacetic Acid REF: 4Z-G-047008CAS: 16817-89-3	- - -	To inquire	Fri 27 Dec 24
Tamoxifen EP Impurity B REF: 4Z-T-0114CAS: 748-97-0	- - -	To inquire	Fri 27 Dec 24
Palbociclib Impurity 29 REF: 4Z-P-196033	- - -	To inquire	Fri 27 Dec 24
Abiraterone Impurity 14 REF: 4Z-A-8251CAS: 93830-58-1	- - -	To inquire	Fri 27 Dec 24
Nintedanib Impurity 23 REF: 4Z-N-066039CAS: 119-63-1	- - -	To inquire	Fri 27 Dec 24
Lenvatinib mesylate REF: TM-T8541CAS: 857890-39-2	99.03% - 99.79%	40.00 €~263.00 €	Fri 27 Dec 24
Palbociclib Impurity 19 REF: 4Z-P-196023CAS: 2324831-15-2	- - -	To inquire	Fri 27 Dec 24
Carfilzomib Impurity 61 REF: 4Z-C-121064	- - -	To inquire	Fri 27 Dec 24
Folitixorin (Mixture of Diastereomers) REF: 4Z-F-068024CAS: 3432-99-3	- - -	To inquire	Fri 27 Dec 24
Gimeracil REF: 4Z-G-047029CAS: 103766-25-2	- - -	To inquire	Fri 27 Dec 24
Lenvatinib Impurity 19 REF: 4Z-L-124024	- - -	To inquire	Fri 27 Dec 24

10mg		39.00 €
25mg		54.00 €
50mg		76.00 €
100mg		97.00 €
500mg		222.00 €

10mg		40.00 €
25mg		59.00 €
50mg		87.00 €
100mg		109.00 €
200mg		162.00 €
500mg		263.00 €

Cancer treatment

1-(Cyclopropylcarbonyl)piperazine Hydrochloride

Ref: 86-MM3926.01-0025

Palbociclib

Ref: 86-MM3729.00-0250

Enzalutamide

Ref: 86-MM3917.00-0250

2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile

Ref: 86-MM3926.07-0025

Fulvestrant

Ref: 86-MM3296.00

Carfilzomib

Ref: 86-MM3929.00-0250

7α-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfonyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol (Fulvestrant Sulfone)

Ref: 86-MM3296.01-0025

Folinic acid

Ref: TM-T24403

Tamoxifen EP Impurity G

Ref: 4Z-T-0118

Oxo-2-pyridinylaminoacetic Acid

Ref: 4Z-G-047008

Tamoxifen EP Impurity B

Ref: 4Z-T-0114

Palbociclib Impurity 29

Ref: 4Z-P-196033

Abiraterone Impurity 14

Ref: 4Z-A-8251

Nintedanib Impurity 23

Ref: 4Z-N-066039

Lenvatinib mesylate

Ref: TM-T8541

Palbociclib Impurity 19

Ref: 4Z-P-196023

Carfilzomib Impurity 61

Ref: 4Z-C-121064

Folitixorin (Mixture of Diastereomers)

Ref: 4Z-F-068024

Gimeracil

Ref: 4Z-G-047029

Lenvatinib Impurity 19

Ref: 4Z-L-124024